The world's largest online retailer got a lift from its booming cloud computing business on Friday, Oct. 31, 2025, while a soft sales outlook weighed on a medical device firm's stock.

Moderna is down 35.3% since the beginning of the year, and at $27.16 per share, it is trading 50.3% below its 52-week high of ...

The health plan sector is in a selloff phase again. Cigna (CI) lost 17.39% on Thursday after posting Q3/2025 results. Cigna ...

Moderna was the only company to participate in the public procurement tender for Covid-19 vaccines, meaning that Hungarian can once again be vaccinated against coronavirus with Moderna vaccines during ...

Major stock indexes declined Thursday as investors digested several big tech earnings reports and awaited more after the ...

Moderna (MRNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

This Nasdaq biotech in my Stocks and Shares ISA portfolio just got a shot in the arm. Here's why I'm almost past caring at this point. The post Up 14% yesterday, is it the end for this train wreck in ...

Key Takeaways A social media giant faltered on Thursday, Oct. 30, 2025, as artificial intelligence costs piled up, while a ...

According to a report from Seeking Alpha, citing Stat News, Moderna has held talks with at least one large drugmaker.

Moderna (NASDAQ:MRNA) stock surged as much as 12% Thursday following a STAT News report that the COVID-19 vaccine maker has been in discussions with at least one large pharmaceutical company about "a ...

The stock market pummeled Cigna after the company revealed its new plan to ditch pharmacy benefit rebates will lower that segment’s profit ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...